NCT01052428View on ClinicalTrials.gov

Molecular Mechanisms of Volume Overload-Aim 1(SCCOR in Cardiac Dysfunction and Disease)

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

August 31, 2004

Primary Completion Date

July 31, 2010

Study Completion Date

July 31, 2010

Conditions
Mitral Regurgitation
Interventions
DRUG

metoprolol succinate (Toprol XL)

Toprol XL 100 mg once a day for 2 years

DRUG

Placebo

Placebo 100 mg once a day for 2 years

Trial Locations (1)

35294-2180

University of Alabama at Birmingham, Birmingham

Sponsors

Collaborators (1)

AstraZeneca
All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

collaborator

AstraZeneca

INDUSTRY

lead

University of Alabama at Birmingham

OTHER